Investors English_20120222

Home Investors Press Releases

Press Releases

Title Filter     Display # 
# Article Title Date
1 3SBio Acquires Sirton Pharmaceuticals SpA 26-Jan-2015
2 3SBio Signs Exclusive Patent License Agreement for Tanibirumab, an Anti-VEGFR2/KDR mAb with PharmAbcine 18-Nov-2014
3 3SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 17-Sep-2014
4 3SBio Signs Exclusive Patent License Agreement with DiNonA for Leukotuximab 08-Aug-2014
5 3SBio Inc. Exclusively Licenses Pegsiticase (Uricase PEG-20) to Selecta Biosciences to Develop Drug Candidate to Treat Gout 18-Jun-2014